Charles River Laboratories International, Inc. (CRL)
168.92
+4.68
(+2.85%)
USD |
NYSE |
Feb 20, 16:00
169.00
+0.08
(+0.05%)
After-Hours: 20:00
Charles River Laboratories International EPS Diluted (Quarterly) : -5.619 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 2.990 |
| DaVita, Inc. | 2.936 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.024 |
| Insulet Corp. | 1.441 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -276.29M |
| Revenue (Quarterly) | 994.23M |
| Total Expenses (Quarterly) | 1.271B |
| Enterprise Value | 10.78B |
| Gross Profit Margin (Quarterly) | 30.96% |
| Profit Margin (Quarterly) | -27.79% |
| Earnings Yield | -1.75% |
| Operating Earnings Yield | 5.98% |
| Normalized Earnings Yield | 2.322 |